Cover Image
市場調查報告書

全球被忽視的熱帶疾病的治療市場預測 (2017∼2027年):瘧疾、登革熱、利什曼原蟲症、血吸蟲症、淋巴管絲蟲症、南美錐蟲病

Global Treatment for Neglected Tropical Disease Market 2017-2027: Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease

出版商 Visiongain Ltd 商品編碼 577295
出版日期 內容資訊 英文 157 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球被忽視的熱帶疾病的治療市場預測 (2017∼2027年):瘧疾、登革熱、利什曼原蟲症、血吸蟲症、淋巴管絲蟲症、南美錐蟲病 Global Treatment for Neglected Tropical Disease Market 2017-2027: Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease
出版日期: 2017年09月20日 內容資訊: 英文 157 Pages
簡介

全球被忽視的熱帶疾病的治療市場,預計2027年以7.3%的年複合成長率擴大。該市場2016年達到了15億美元。其中瘧疾佔市場30%。

本報告提供全球被忽視的熱帶疾病的治療市場相關調查,今後的收益預測,各類型,各地區的趨勢,及加入此市場的主要企業的簡介等彙整。

第1章 本報告概要

第2章 簡介

第3章 全球被忽視的熱帶疾病的治療市場

  • 市場預測
  • 各分類市場佔有率
  • 瘧疾
  • 登革熱
  • 利什曼原蟲症
  • 血吸蟲症
  • 淋巴管絲蟲症
  • 南美錐蟲病
  • 其他

第4章 主要國家市場

  • 各地區明細
  • 各地區預測
  • 到2027年的市場佔有率的變化

第5章 北美市場

第6章 歐洲市場

第7章 亞太地區市場

第8章 南美市場

第9章 中東、非洲市場

第10章 主要企業

  • Pfizer, Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • 武田藥品工業株式會社
  • Eisai株式會社

第11章 結論

目錄
Product Code: PHA0240

The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 157-page report you will receive 71 tables and 80 figures- all unavailable elsewhere.

The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Treatment for Neglected Tropical Disease market forecasts from 2017-2027

image1

  • This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type:
    • Malaria treatments
    • Dengue treatments
    • Leishmaniasis
    • Schistosomiasis
    • Lymphatic Filariasis
    • Chagas Disease
    • Others

For each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.

  • This report provides revenue forecast for these leading drugs:
    • Coartem (Novartis)
    • Clindamycin (Pfizer)
    • Dengvaxia (Sanofi)
    • AmBisome (Gilead Sciences)
    • Impavido (Knight Therapeutics)
    • ALBENZA (Amedra Pharmaceuticals LLC)
  • This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:
    • North America: US and Canada
    • Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
    • Asia-Pacific: Japan, China, India, Rest of Asia
    • Latin America: Brazil, Mexico, Rest of Latin America
    • Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & Africa

Each regional market is further broken down by disease type.

  • This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:
    • Pfizer, Inc.
    • Bayer
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Novartis International AG
    • Takeda Pharmaceutical Company Ltd
    • Sanofi S.A.
    • Eisai Co., Ltd

Table of Contents

1. Report Overview

  • 1.1 Global Treatment for Neglected Tropical Disease Market Overview
  • 1.2 Overview of Findings
  • 1.3 Structure of the Report
  • 1.4 Global Treatment for Neglected Tropical Disease Market Segmentation
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8 Who is This Report For?
  • 1.9 Methodology
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2. Introduction to Treatment for Neglected Tropical Disease

  • 2.1 An Introduction to Treatment for Neglected Tropical Disease
  • 2.2. Malaria Treatments
  • 2.3. Dengue Treatments
  • 2.4. Leishmaniasis
  • 2.5 Schistosomiasis
  • 2.6 Lymphatic Filariasis
  • 2.7 Chagas Disease
  • 2.8. Drivers
    • 2.8.1. Increasing prevalence of various neglected tropical disease
    • 2.8.2. Product Launch and Government Initiatives
  • 2.9. Restrains
    • 2.9.1 High Possibilities of Side Effect of Vaccine

3. Global Treatment for Neglected Tropical Disease Market 2017-2027

  • 3.1 Global Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 3.2 Changing Market Shares by Segment2017-2027
  • 3.3 Global Malaria Treatments Segment Market: Sales Forecast 2017-2027
    • 3.3.1. Leading Drugs in the Malaria Treatments Market
      • 3.3.1.1. Coartem (Novartis)
      • 3.3.1.2. Clindamycin (Pfizer, Inc.)
      • 3.3.1.3. Other Malaria Drugs
    • 3.3.2. SWOT Analysis of the Malaria Treatments Market, 2017-2027
      • 3.3.2.1. Strength
        • 3.3.2.1.1. Supportive Government policy for Primary Health Care strategies
      • 3.3.2.2. Weakness
        • 3.3.2.2.1. Inadequacies in public health infrastructure, including training facilities
      • 3.3.2.3. Opportunity
        • 3.3.2.3.1. Increasing prevalence of Malaria
      • 3.3.2.4. Threat
        • 3.3.2.4.1. Community resistance to surveillance activities
  • 3.4 Global Dengue treatments Segment Market: Sales Forecast 2017-2027
    • 3.4.1. Dengvaxia (Sanofi)
    • 3.4.2. SWOT Analysis of the Dengue Treatments Market, 2017-2027
      • 3.4.2.1. Strength
        • 3.4.2.1.1. Approval of Dengvaxia
      • 3.4.2.2. Weakness
        • 3.3.2.2.1. Vaccine is not available worldwide
      • 3.4.2.3. Opportunity
        • 3.4.2.3.1. Increasing prevalence of Dengue
      • 3.4.2.4. Threat
        • 3.4.2.4.1. Side Effects of Dengvaxia
  • 3.5 Global Leishmaniasis Segment Market: Sales Forecast 2017-2027
    • 3.5.1. AmBisome (Gilead Sciences)
    • 3.5.2. Impavido (Marketed by Knight Therapeutics)
    • 3.5.3. Leishmaniasis Drugs
    • 3.5.4. SWOT Analysis of the Leishmaniasis Market, 2017-2027
      • 3.5.4.1. Strength
        • 3.5.4.1.1. Availability of vaccines
      • 3.5.4.2. Weakness
        • 3.5.4.2.1. No or less prevalence in developed regions
      • 3.5.4.3. Opportunity
        • 3.5.4.3.1. Increasing Prevalence of Visceral leishmaniasis
      • 3.5.4.4. Threat
        • 3.5.4.4.1. Patient don't know if they are infected
  • 3.6 Global Schistosomiasis Segment Market: Sales Forecast 2017-2027
    • 3.6.1. SWOT Analysis of the Schistosomiasis Market, 2017-2027
      • 3.6.1.1. Strength
        • 3.6.1.1.1. Increasing prevalence of Schistosomiasis
      • 3.6.1.2. Weakness
        • 3.6.1.2.1. No or less prevalence in North America and Europe
      • 3.6.1.3. Opportunity
        • 3.6.1.3.1. Major patient base in Middle East & Africa
      • 3.6.1.4. Threat
        • 3.6.1.4.1. New Entrants
  • 3.7 Global Lymphatic Filariasis Segment Market: Sales Forecast 2017-2027
    • 3.7.1. ALBENZA (Amedra Pharmaceuticals LLC)
    • 3.7.2. Lymphatic Filariasis Drugs
    • 3.7.3. SWOT Analysis of the Lymphatic Filariasis Market, 2017-2027
      • 3.7.3.1. Strength
        • 3.7.3.1.1. Increasing number of patient treated with lymphatic filariasis
      • 3.7.3.2. Weakness
        • 3.7.3.2.1. Availability of vaccine for the patients
      • 3.7.3.3. Opportunity
        • 3.7.3.3.1. Increasing prevalence of Lymphatic Filariasis
      • 3.7.3.4. Threat
        • 3.7.3.4.1. Side Effects of ALBENZA
  • 3.8 Global Chagas Disease Segment Market: Sales Forecast 2017-2027
    • 3.8.1. Chagas Disease Drugs
    • 3.8.2. SWOT Analysis of the Chagas Disease Market, 2017-2027
      • 3.8.2.1. Strength
        • 3.8.2.1.1. Increasing prevalence rate of underdiagnosed migrants
      • 3.8.2.2. Weakness
        • 3.8.2.2.1. Low prevalence of Chagas Disease in Asia-Pacific and Middle East & Africa
      • 3.8.2.3. Opportunity
        • 3.8.2.3.1. Increasing prevalence of Chagas Disease
      • 3.8.2.4. Threat
        • 3.8.2.4.1. Neglected by market players
  • 3.9 Global Others Segment Market: Sales Forecast 2017-2027

4.Leading National Markets 2017-2027

  • 4.1 Geographical Breakdown of the World Treatment for Neglected Tropical Disease Market
  • 4.2 World Treatment for Neglected Tropical Disease Market: Regional Forecast 2017-2027
  • 4.2.1 How Will Regional Market Shares Change to 2027?

5. North America Treatment for Neglected Tropical Disease Market 2017-2027

  • 5.1. U.S. Treatment for Neglected Tropical Disease Market: Trends and Developments
  • 5.2. Canada Treatment for Neglected Tropical Disease Market: Trends and Developments

6. Europe Treatment for Neglected Tropical Disease Market 2017-2027

  • 6.1. Germany Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 6.2. France Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 6.3. U.K. Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 6.4. Italy Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 6.5. Spain Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 6.6. Rest of Europe Treatment for Neglected Tropical Disease Market Forecast 2017-2027

7. Asia-Pacific Treatment for Neglected Tropical Disease Market 2017-2027

  • 7.1. China Treatment for Neglected Tropical Disease Market: Trends and Developments
  • 7.2. Japan Treatment for Neglected Tropical Disease Market: Trends and Developments
  • 7.3. India Treatment for Neglected Tropical Disease Market: Trends and Developments
  • 7.4. Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market: Trends and Developments

8. Latin America Treatment for Neglected Tropical Disease Market 2017-2027

  • 8.1 Brazil Treatment for Neglected Tropical Disease Market: Trends and Developments
  • 8.2. Mexico Treatment for Neglected Tropical Disease Market: Trends and Developments
  • 8.3. Rest of Latin America Treatment for Neglected Tropical Disease Market: Trends and Developments

9. Middle East and Africa Treatment for Neglected Tropical Disease Market 2017-2027

  • 9.1. Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 9.2. South Africa Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 9.3. Rest of Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast 2017-2027

10. Leading Companies in the Treatment for Neglected Tropical Disease Market

  • 10.1. Pfizer, Inc.
    • 10.1.1 Pfizer, Inc.: Treatment for Neglected Tropical Disease Product Portfolio
    • 10.1.2 Pfizer, Inc.: Financial Overview
    • 10.1.3 Pfizer, Inc.: Recent Developments
  • 10.2. Bayer AG
    • 10.2.1 Bayer AG: Treatment for Neglected Tropical Disease Portfolio
    • 10.2.2 Bayer AG: Financial Overview
    • 10.2.3 Bayer AG: Recent Transactions Summary
  • 10.3. GlaxoSmithKline plc
    • 10.3.1 GlaxoSmithKline plc: Treatment for Neglected Tropical Disease Portfolio
    • 10.3.2 GlaxoSmithKline plc: Financial Overview
    • 10.3.3 GlaxoSmithKline plc: Recent Transactions Summary
  • 10.4. Merck & Co., Inc.
    • 10.4.1 Merck & Co., Inc.: Treatment for Neglected Tropical Disease Portfolio
    • 10.4.2 Merck & Co., Inc.: Financial Overview
    • 10.4.3 Merck & Co., Inc.: Recent Transactions Summary
  • 10.5. Novartis AG
    • 10.5.1 Novartis: Treatment for Neglected Tropical Disease Product Portfolio
    • 10.5.2 Novartis: Financial Overview
    • 10.5.3 Novartis: Recent Developments
  • 10.6. Takeda Pharmaceutical Company Ltd
    • 10.6.1 Takeda Pharmaceutical Company Ltd: Treatment for Neglected Tropical Disease Product Portfolio
    • 10.6.2 Takeda Pharmaceutical Company Ltd: Financial Overview
    • 10.6.3 Takeda Pharmaceutical Company Ltd: Recent Developments
  • 10.7. Sanofi S.A.
    • 10.7.1 Sanofi S.A.: Treatment for Neglected Tropical Disease Product Portfolio
    • 10.7.2 Sanofi S.A.: Financial Overview
    • 10.7.3 Sanofi S.A.: Recent Developments
  • 10.8. Eisai Co., Ltd
    • 10.8.1 Eisai Co., Ltd: Treatment for Neglected Tropical Disease Product Portfolio
    • 10.8.2 Eisai Co., Ltd: Financial Overview
    • 10.8.3 Eisai Co., Ltd: Recent Developments

11. Conclusions

  • 11.1 The World Treatment for Neglected Tropical Disease Market in 2016 and 2016
    • 11.1.1 Current Leading Treatment for Neglected Tropical Disease Segments
    • 11.1.2 Leading Regional Markets
  • 11.2 World Treatment for Neglected Tropical Disease Market Forecast 2017-2027
  • 11.3 The Future of the Treatment for Neglected Tropical Disease Market?

Appendices

  • Associated Visiongain Report
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 3.1 Global Treatment for Neglected Tropical Disease Market by Diseases Types: Revenue ($m) and Market Share (%), 2016
  • Table 3.2 Global Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.3 Global Malaria Treatments Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.4 Global Coartem Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.5 Global Clindamycin Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.6 Other Malaria Drugs
  • Table 3.7 SWOT Analysis of the Malria Market, 2017-2027
  • Table 3.8 Global Dengue Treatments Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.9 Global Dengvaxia Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.10 SWOT Analysis of the Dengue Treatment Market, 2017-2027
  • Table 3.11 Global Leishmaniasis Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.12 Global AmBisome Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.13 Global Impavido Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.14 Other Leishmaniasis Drugs
  • Table 3.15 SWOT Analysis of the Leishmaniasis Market, 2017-2027
  • Table 3.16 Global Schistosomiasis Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.17 SWOT Analysis of the Schistosomiasis Market, 2017-2027
  • Table 3.18 Global Lymphatic Filariasis Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.19 Global ALBENZA Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.20 Other Lymphatic Filariasis Drugs
  • Table 3.21 SWOT Analysis of the Lymphatic Filariasis Market, 2017-2027
  • Table 3.22 Global Chagas Disease Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 3.23 Other Chagas Disease Drugs
  • Table 3.24 SWOT Analysis of the Chagas Disease Market, 2017-2027
  • Table 3.25 Global Others Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 4.1 Global Treatment for Neglected Tropical Disease Market by Region: Revenue ($m), 2016 and 2017
  • Table 4.2 Global Treatment for Neglected Tropical Disease Market Forecast, by Region: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 5.1 North America Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 5.2 North America Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
  • Table 5.3 U.S. Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 5.4 Canada Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 6.1 Europe Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 6.2 Europe Treatment for Neglected Tropical Disease Market Forecast, By Country: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 6.3 Germany Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 6.4 France Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 6.5 U.K. Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 6.6 Italy Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 6.7 Spain Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 6.8 Rest of Europe Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 7.1 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 7.2 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
  • Table 7.3 China Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 7.4 Japan Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 7.5 India Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 7.6 Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 8.1 Latin America Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 8.2 Latin America Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
  • Table 8.3 Brazil Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 8.4 Mexico Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 8.5 Rest of Latin America Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 9.1 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
  • Table 9.2 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast, by Country 2016-2027 ($m, AGR %, CAGR %)
  • Table 9.3 Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 9.4 South Africa Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 9.5 Rest of MEA Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
  • Table 10.1 Pfizer, Inc.: Overview, 2017
  • Table 10.2 Pfizer, Inc.: Revenue ($m), AGR (%), 2012-2016
  • Table 10.3 Bayer AG: Overview, 2017
  • Table 10.4 Bayer AG: Revenue ($m), AGR (%), 2012-2016
  • Table 10.5 GlaxoSmithKline plc: Overview, 2017
  • Table 10.6 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2012-2016
  • Table 10.7 Merck & Co., Inc.: Overview, 2017
  • Table 10.8 Merck & Co., Inc.: Revenue ($m), AGR (%), 2012-2016
  • Table 10.9 Novartis: Overview, 2017
  • Table 10.10 Novartis: Revenue ($m), AGR (%), 2012-2016
  • Table 10.11 Takeda Pharmaceutical Company Ltd: Overview, 2017
  • Table 10.12 Takeda Pharmaceutical Company Ltd: Revenue ($m), AGR (%), 2012-2016
  • Table 10.13 Sanofi S.A.: Overview, 2017
  • Table 10.14 Sanofi S.A.: Revenue ($m), AGR (%), 2012-2016
  • Table 10.15 Eisai Co., Ltd: Overview, 2017
  • Table 10.16 Eisai Co., Ltd: Revenue ($m), AGR (%), 2011-2015

List of Figure

  • Figure 1.1 Global Treatment for Neglected Tropical Disease Market Segmentation Overview
  • Figure 3.1 Global Treatment for Neglected Tropical Disease Market by Diseases Type: Market Share (%), 2016
  • Figure 3.2 Global Treatment for Neglected Tropical Disease Market Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.3 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2016
  • Figure 3.4 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2021
  • Figure 3.5 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2027
  • Figure 3.6 Global Malaria Treatments Segment Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.7 Global Coartem Market Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.8 Global Clindamycin Market Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.9 Global Dengue Treatments Segment Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.10 Global Dengvaxia Market Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.11 Global Leishmaniasis Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.12 Global AmBisome Market Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.13 Global Impavido Market Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.14 Global Schistosomiasis Segment Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.15 Global Lymphatic Filariasis Segment Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.16 Global ALBENZA Segment Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.17 Global Chagas Disease Segment Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 3.18 Global Others Segment Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 4.1 World Treatment for Neglected Tropical Disease Market: Revenues ($m) by Region, 2016
  • Figure 4.2 World Treatment for Neglected Tropical Disease Market: Revenues ($m) by Region, 2017
  • Figure 4.3 Global Treatment for Neglected Tropical Disease Market Forecast: Revenue ($m), AGR (%), 2016-2027
  • Figure 4.4 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2016
  • Figure 4.5 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2021
  • Figure 4.6 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2027
  • Figure 5.1 North America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 5.2 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
  • Figure 5.3 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
  • Figure 5.4 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
  • Figure 5.5 US Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 5.6 Canada Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 6.1 Europe Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 6.2 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
  • Figure 6.3 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
  • Figure 6.4 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
  • Figure 6.5 Germany Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 6.6 France Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 6.7 U.K. Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 6.8 Italy Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 6.9 Spain Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 6.10 Rest of Europe Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 7.1 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 7.2 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
  • Figure 7.3 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
  • Figure 7.4 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
  • Figure 7.5 China Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 7.6 Japan Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 7.7 India Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 7.8 Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 8.1 Latin America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 8.2 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
  • Figure 8.3 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
  • Figure 8.4 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
  • Figure 8.5 Brazil Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 8.6 Mexico Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 8.7 Rest of Latin America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 9.1 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 9.2 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
  • Figure 9.3 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
  • Figure 9.4 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
  • Figure 9.5 Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 9.6 South Africa Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 9.7 Rest of MEA Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
  • Figure 10.1 Pfizer, Inc.: Revenue ($m), AGR (%), 2012-2016
  • Figure 10.2 Pfizer, Inc.: National Revenue Share (%), 2016
  • Figure 10.3 Bayer AG: Revenue ($m), AGR (%), 2012-2016
  • Figure 10.4 Bayer AG: Business Segment Revenue Share (%), 2016
  • Figure 10.5 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2012-2016
  • Figure 10.6 GlaxoSmithKline plc: Business Segment Revenue Share (%), 2016
  • Figure 10.7 Merck & Co., Inc.: Revenue ($m), AGR (%), 2012-2016
  • Figure 10.8 Merck & Co., Inc.: Business Segment Revenue Share (%), 2016
  • Figure 10.9 Novartis: Revenue ($m), AGR (%), 2012-2016
  • Figure 10.10 Novartis: Revenue, by Region, Share (%), 2016
  • Figure 10.11 Takeda Pharmaceutical Company Ltd: Revenue ($m), AGR (%), 2012-2016
  • Figure 10.12 Takeda Pharmaceutical Company Ltd: Revenue, by Region, Share (%), 2016
  • Figure 10.13 Sanofi S.A.: Revenue ($m), AGR (%), 2012-2016
  • Figure 10.14 Sanofi S.A.: Revenue, by Region, Share (%), 2016
  • Figure 10.15 Eisai Co., Ltd: Revenue ($m), AGR (%), 2011-2015
  • Figure 11.1 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2016
  • Figure 11.2 Treatment for Neglected Tropical Disease Market, By Region Share (%), 2016, 2021, 2027

Companies Listed

  • Actiza Pharmaceutical
  • Amedra Pharmaceuticals LLC
  • APP Pharmaceuticals LLC
  • Asian Development Bank
  • Bayer
  • Bristol-Myers Squibb
  • Comic Relief
  • Cyper Pharma
  • Eisai Co., Ltd
  • F. Hoffmann-La Roche AG
  • Gilead Sciences
  • GlaxoSmithKline plc
  • Janssen
  • Johnson & Johnson
  • Kadmon Pharmaceuticals LLC
  • Knight Therapeutics
  • Merck
  • Nicholas Piramal India Ltd.
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Ltd

List of Organizations Mentioned in The Report

  • Asia-Pacific Leaders Malaria Alliance (APLMA)
  • Australian Institute of Tropical Health and Medicine
  • Baylor College of Medicine
  • Centers for Disease Control and Prevention (CDC)
  • Department of Health Philippines
  • Drugs for Neglected Diseases Initiative (DNDi)
  • Emerging Infectious Diseases Journal (EID)
  • European Centre for Disease Control and Prevention (ECDC)
  • Eurosurveillance
  • Food and Drug Administration (FDA)
  • Global Health Innovative Technology Fund (GHIT Fund)
  • GOV.UK
  • International Cardiovascular Forum Journal
  • Liverpool School of Tropical Medicine
  • Malaria Journal
  • Malaysian Medical Association
  • Malaysian Pharmaceutical Society and Guardian Health & Beauty
  • Medicines for Malaria Venture
  • Ministry of Health - Kingdom of Saudi Arabia
  • Ministry of Health Malaysia
  • Ministry of Health, Labour and Welfare Japan
  • National Center for Biotechnology Information (NCBI)
  • National Vector Borne Disease Control Programme (NVBDCP)
  • Pan American Health Organization (PAHO)
  • Public Library of Science (PLOS)
  • Roll Back Malaria
  • The End Fund
  • The Gates Foundation
  • The United States Agency for International Development (USAID)
  • University of Liverpool
  • WHO Western Pacific Region (WPRO)
  • World Health Organization (WHO)
Back to Top